Quick Links

City of Hope scientist receives prestigious award from NCI 

Leslie Bernstein, Ph.D., honored for research on lifestyle choices’ link to cancer risk 


Contact: H. Chung So
800-888-5323
hso@coh.org


DUARTE, Calif., January 26, 2010 The National Cancer Institute (NCI) has honored Leslie Bernstein, Ph.D., director of City of Hope’s Division of Cancer Etiology, with its Rosalind E. Franklin Award. The award recognizes the commitment of women to cancer research.

Bernstein was honored at the NCI annual retreat in Bethesda, Md. In addition to receiving the award, Bernstein delivered a lecture on reducing breast cancer risk through biology and epidemiology.

“Dr. Bernstein not only has contributed important findings to the field of cancer epidemiology, but she commits her time to mentor other young scientists and lend her biostatistical knowledge to countless studies,” said Smita Bhatia, M.D., M.P.H., chair of City of Hope’s Department of Population Sciences. “We’re delighted to see her honored by her peers.”

Bernstein’s research primarily has focused on how personal and lifestyle factors affect risk of breast cancer and other malignancies including non-Hodgkin’s lymphoma. She also has studied how such lifestyle factors influence disease prognosis and quality of life among survivors.

She contributes to national and international research, serving as a chair or member of several advisory committees for studies significant to women’s health, including the Nurse’s Health Study at Harvard University and the Breakthrough Generations Breast Cancer Program in the U.K.  Bernstein also serves as president for the Society of Epidemiologic Research.

The award is sponsored by the National Institutes of Health Women Scientist Advisors. Named after a pioneering female scientist instrumental to the discovery of the DNA double helix, the award highlights prominent women who have distinguished themselves in the investigation of cancer and its origins and treatment. Bernstein is the ninth researcher to receive the award since it was established last decade.

About City of Hope 

City of Hope is a leading research, treatment and education center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest honor bestowed by the National Cancer Institute, and a founding member of the National Comprehensive Cancer Network, City of Hope's research and treatment protocols advance care throughout the nation. City of Hope is located in Duarte, Calif., just northeast of Los Angeles, and is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on Facebook, Twitter, YouTube or Flickr. Learn more >>

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.